Melanie Davies, Louise Færch, Ole K Jeppesen, Arash Pakseresht, Sue D Pedersen, Leigh Perreault, Julio Rosenstock, Iichiro Shimomura, Adie Viljoen, Thomas A Wadden, Ildiko Lingvay. Lancet 2021
Times Cited: 170
Times Cited: 170
Kishore M Gadde, David B Allison, Donna H Ryan, Craig A Peterson, Barbara Troupin, Michael L Schwiers, Wesley W Day. Lancet 2011
Times Cited: 529
Times Cited: 529
List of shared articles
Times cited
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023.
Nuha A ElSayed, Grazia Aleppo, Vanita R Aroda, Raveendhara R Bannuru, Florence M Brown, Dennis Bruemmer, Billy S Collins, Marisa E Hilliard, Diana Isaacs, Eric L Johnson,[...]. Diabetes Care 2023
Nuha A ElSayed, Grazia Aleppo, Vanita R Aroda, Raveendhara R Bannuru, Florence M Brown, Dennis Bruemmer, Billy S Collins, Marisa E Hilliard, Diana Isaacs, Eric L Johnson,[...]. Diabetes Care 2023
An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal.
Connor Enright, Elizabeth Thomas, David R Saxon. J Endocr Soc 2023
Connor Enright, Elizabeth Thomas, David R Saxon. J Endocr Soc 2023
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation.
Ildiko Lingvay, Priya Sumithran, Ricardo V Cohen, Carel W le Roux. Lancet 2022
Ildiko Lingvay, Priya Sumithran, Ricardo V Cohen, Carel W le Roux. Lancet 2022
High-Dose Once-Weekly Semaglutide: A New Option for Obesity Management.
Courtney L Bradley, Sara M McMillin, Andrew Y Hwang, Christina H Sherrill. Ann Pharmacother 2022
Courtney L Bradley, Sara M McMillin, Andrew Y Hwang, Christina H Sherrill. Ann Pharmacother 2022
Anti-obesity drug discovery: advances and challenges.
Timo D Müller, Matthias Blüher, Matthias H Tschöp, Richard D DiMarchi. Nat Rev Drug Discov 2022
Timo D Müller, Matthias Blüher, Matthias H Tschöp, Richard D DiMarchi. Nat Rev Drug Discov 2022
New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications.
W Timothy Garvey. J Clin Endocrinol Metab 2022
W Timothy Garvey. J Clin Endocrinol Metab 2022
Pharmacotherapy of obesity in complex diseases.
Vishnu Priya Pulipati, Silvana Pannain. Clin Obes 2022
Vishnu Priya Pulipati, Silvana Pannain. Clin Obes 2022
Managing weight and glycaemic targets in people with type 2 diabetes-How far have we come?
Matthias Blüher, Antonio Ceriello, Melanie Davies, Helena Rodbard, Naveed Sattar, Oliver Schnell, Elena Tonchevska, Francesco Giorgino. Endocrinol Diabetes Metab 2022
Matthias Blüher, Antonio Ceriello, Melanie Davies, Helena Rodbard, Naveed Sattar, Oliver Schnell, Elena Tonchevska, Francesco Giorgino. Endocrinol Diabetes Metab 2022
Pharmacological profile of once-weekly injectable semaglutide for chronic weight management.
David C W Lau, Rachel L Batterham, Carel W le Roux. Expert Rev Clin Pharmacol 2022
David C W Lau, Rachel L Batterham, Carel W le Roux. Expert Rev Clin Pharmacol 2022
Anti-obesity weight loss medications: Short-term and long-term use.
Dagam Jeong, Ronny Priefer. Life Sci 2022
Dagam Jeong, Ronny Priefer. Life Sci 2022
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
Lawrence Blonde, Guillermo E Umpierrez, S Sethu Reddy, Janet B McGill, Sarah L Berga, Michael Bush, Suchitra Chandrasekaran, Ralph A DeFronzo, Daniel Einhorn, Rodolfo J Galindo,[...]. Endocr Pract 2022
Lawrence Blonde, Guillermo E Umpierrez, S Sethu Reddy, Janet B McGill, Sarah L Berga, Michael Bush, Suchitra Chandrasekaran, Ralph A DeFronzo, Daniel Einhorn, Rodolfo J Galindo,[...]. Endocr Pract 2022
Signaling pathways in obesity: mechanisms and therapeutic interventions.
Xue Wen, Bohan Zhang, Beiyi Wu, Haitao Xiao, Zehua Li, Ruoyu Li, Xuewen Xu, Tao Li. Signal Transduct Target Ther 2022
Xue Wen, Bohan Zhang, Beiyi Wu, Haitao Xiao, Zehua Li, Ruoyu Li, Xuewen Xu, Tao Li. Signal Transduct Target Ther 2022